29 Sept 2026, 16:11
Meetings & Governance—
EYENOVA EYE MEDICAL LIMITED
Announcement history available from 1 August 2025
Fromto
22 Sept 2026, 09:13
Securities Administration—
22 Sept 2026, 09:11
Securities Administration—
21 Sept 2026, 09:09
Securities Administration—
3 Sept 2026, 16:55
Meetings & Governance—
28 Aug 2026, 15:21
Director Interests—
26 Aug 2026, 17:31
Company Administration—
26 Aug 2026, 17:04
Financial ResultsMS
26 Aug 2026, 16:55
Financial ResultsMS
5 Aug 2026, 12:41
Securities Administration—
29 July 2026, 11:10
Presentations—
29 July 2026, 11:03
Quarterly ReportsMS
10 July 2026, 14:39
Securities Administration—
25 June 2026, 14:55
Securities Administration—
25 June 2026, 14:49
Securities Administration—
6 May 2026, 15:04
Securities Administration—
6 May 2026, 15:02
Securities Administration—
5 May 2026, 09:48
Periodic ReportsMS
5 May 2026, 09:47
Presentations—
30 Apr 2026, 10:27
Presentations—
29 Apr 2026, 08:26
Quarterly ReportsMS
11 Mar 2026, 09:31
Securities Administration—
3 Mar 2026, 09:14
Company Update—
26 Feb 2026, 08:23
Presentations—
26 Feb 2026, 08:16
Financial Results—
26 Feb 2026, 08:16
Financial ResultsMS
26 Feb 2026, 08:15
Financial ResultsMS
11 Feb 2026, 13:46
Company Administration—
4 Feb 2026, 11:30
Company Administration—
29 Jan 2026, 15:23
Presentations—
29 Jan 2026, 08:44
Quarterly ReportsMS
27 Jan 2026, 09:45
Company Update—
19 Jan 2026, 10:24
Presentations—
15 Jan 2026, 09:09
Presentations—
12 Jan 2026, 09:46
Periodic ReportsMS
5 Dec 2025, 10:34
Securities Administration—
5 Dec 2025, 10:26
Securities Administration—
27 Nov 2025, 13:48
Meetings & Governance—
27 Nov 2025, 10:30
Presentations—
27 Nov 2025, 10:28
Letters & Addresses—
17 Nov 2025, 14:37
Company Administration—
5 Nov 2025, 11:32
PresentationsMS
31 Oct 2025, 08:27
Quarterly ReportsMS
30 Oct 2025, 18:26
Presentations—
28 Oct 2025, 14:45
Meetings & Governance—
1 Oct 2025, 17:02
Meetings & Governance—
30 Sept 2025, 09:24
Company UpdateMS
15 Sept 2025, 10:40
Securities Administration—
15 Sept 2025, 10:38
Securities Administration—
15 Sept 2025, 10:33
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 29 Sept 2026, 16:11 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 22 Sept 2026, 09:13 | Cleansing Notice | Securities Administration | — | 06018 | |
| 22 Sept 2026, 09:11 | Application for quotation of securities - EYE | Securities Administration | — | 06020 | |
| 21 Sept 2026, 09:09 | Proposed issue of securities - EYE | Securities Administration | — | 06013 | |
| 3 Sept 2026, 16:55 | AGM date and closing date for Director Nominations | Meetings & Governance | — | 08006 | |
| 28 Aug 2026, 15:21 | Appendix 3 Y T A Spurling | Director Interests | — | 02009 | |
| 26 Aug 2026, 17:31 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 26 Aug 2026, 17:04 | Full Year Financial Results | Financial Results | MS | 03003 | |
| 26 Aug 2026, 16:55 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 5 Aug 2026, 12:41 | Notification of cessation of securities - EYE | Securities Administration | — | 06027 | |
| 29 July 2026, 11:10 | Investor Webinar Tuesday 4 August 2026 @ 11.30 AEST | Presentations | — | 14014 | |
| 29 July 2026, 11:03 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 10 July 2026, 14:39 | Application for quotation of securities - EYE | Securities Administration | — | 06020 | |
| 25 June 2026, 14:55 | Notification of cessation of securities - EYE | Securities Administration | — | 06027 | |
| 25 June 2026, 14:49 | Notification of cessation of securities - EYE | Securities Administration | — | 06027 | |
| 6 May 2026, 15:04 | Notification regarding unquoted securities - EYE | Securities Administration | — | 06021 | |
| 6 May 2026, 15:02 | Application for quotation of securities - EYE | Securities Administration | — | 06020 | |
| 5 May 2026, 09:48 | EYE lifts Sales Guidance | Periodic Reports | MS | 03014 | |
| 5 May 2026, 09:47 | Q3FY26 Investor Presentation May26 | Presentations | — | 03026 | |
| 30 Apr 2026, 10:27 | Investor Webinar Tuesday 5 May @ 11.30 AEST | Presentations | — | 14014 | |
| 29 Apr 2026, 08:26 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 11 Mar 2026, 09:31 | Application for quotation of securities - EYE | Securities Administration | — | 06020 | |
| 3 Mar 2026, 09:14 | EYE Receives EU MDR Certification | Company Update | — | 11001 | |
| 26 Feb 2026, 08:23 | Investor Webinar Tuesday 3 March @11.30 AEDT | Presentations | — | 14014 | |
| 26 Feb 2026, 08:16 | Investor Presentation Half Year Results | Financial Results | — | 03004, 03026 | |
| 26 Feb 2026, 08:16 | EYE Delivers Sales Growth and Improves Bottom Line | Financial Results | MS | 03004, 03014 | |
| 26 Feb 2026, 08:15 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 11 Feb 2026, 13:46 | Re-lodgement of Appendix 4G | Company Administration | — | 03025, 12008 | |
| 4 Feb 2026, 11:30 | Peer-Reviewed Real-World Evidence Supports iTrack | Company Administration | — | 12008 | |
| 29 Jan 2026, 15:23 | Investor Webinar Monday 2 February @ 11.30 AEDT | Presentations | — | 12008, 14014 | |
| 29 Jan 2026, 08:44 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 27 Jan 2026, 09:45 | ITrack Registry Clinical Data Update | Company Update | — | 11001 | |
| 19 Jan 2026, 10:24 | Investor Webinar Presentation December 2025 | Presentations | — | 03026 | |
| 15 Jan 2026, 09:09 | Investor Webinar 19 January 2026 | Presentations | — | 14014 | |
| 12 Jan 2026, 09:46 | Record Sales Result December 2025 Quarter | Periodic Reports | MS | 03014 | |
| 5 Dec 2025, 10:34 | Notification regarding unquoted securities - EYE | Securities Administration | — | 06021 | |
| 5 Dec 2025, 10:26 | Application for quotation of securities - EYE | Securities Administration | — | 06020 | |
| 27 Nov 2025, 13:48 | EYE AGM 2025 Meeting Results | Meetings & Governance | — | 08003 | |
| 27 Nov 2025, 10:30 | AGM 2025 Presentation | Presentations | — | 03026, 15002 | |
| 27 Nov 2025, 10:28 | AGM 2025 Chairmans Address | Letters & Addresses | — | 15002 | |
| 17 Nov 2025, 14:37 | EYE Investor Webinar iTrack in Practice | Company Administration | — | 12008 | |
| 5 Nov 2025, 11:32 | Investor Webinar | Presentations | MS | 03026 | |
| 31 Oct 2025, 08:27 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 30 Oct 2025, 18:26 | Investor Webinar 5 November 2025 @11.30 am AEDT | Presentations | — | 14014 | |
| 28 Oct 2025, 14:45 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 1 Oct 2025, 17:02 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006, 12008 | |
| 30 Sept 2025, 09:24 | iTrack Advance Approved for Sale in China | Company Update | MS | 11001 | |
| 15 Sept 2025, 10:40 | Notification of cessation of securities - EYE | Securities Administration | — | 06027 | |
| 15 Sept 2025, 10:38 | Notification regarding unquoted securities - EYE | Securities Administration | — | 06021 | |
| 15 Sept 2025, 10:33 | Application for quotation of securities - EYE | Securities Administration | — | 06020 |
1–50 of 58
1 / 2